Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders

References

• Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators. Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012; 61: 1–19.
   Google Scholar
• Cody H, Pelphrey K, Piven J. Structural and functional magnetic resonance imaging of autism. Int J Dev Neurosci. 2002; 20: 421–38. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Courchesne E, Pierce K. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci. 2005; 23: 153–70. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci. 2005; 23: 183–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry. 2005; 59: 354–63. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Araghi-Niknam M, Fatemi SH. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol. 2003; 23: 945–52. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Palomo T, Beninger RJ, Kostrzewa RM, Archer T. Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations. Neurotox Res. 2003; 5: 1–26. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Raymond GV, Bauman ML, Kemper TL. Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl). 1996; 91: 117–19. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Bittman K, Becker DL, Cicirata F, Parnavelas JG. Connexin expression in homotypic and heterotypic cell coupling in the developing cerebral cortex. J Comp Neurol. 2002; 443: 201–12. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Kirchhoff F, Dringen R, Giaume C. Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur Arch Psychiatry Clin Neurosci. 2001; 251: 159–69. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Carper RA, Moses P, Tigue ZD, Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage. 2002; 16: 1038–51. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Hendry J, Devito T, Gelman N, Densmore M, Rajakumar N, Pavlosky W, et al. White matter abnormalities in autism detected through transverse relaxation time imaging. Neuroimage. 2006; 29: 1049–57. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005; 57: 67–81. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Court P, et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. 2005; 172: 198–205. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Ameis SH, Szatmari P. Imaging-genetics in autism spectrum disorder: advances, translational impact, and future directions. Front Psychiatry. 2012; 3: 46. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Hu VW, Frank BC, Heine S, Lee NH, Quackenbush J. Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics. 2006; 7: 118. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002; 46: 76–84. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005; 23: 189–99. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Herbert MR. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol. 2010; 23: 103–10. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012; 17: 389–401. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Frye RE, Rossignol DA. Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res. 2011; 69: 41R–7R. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2011; 17: 290–314. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. 2009; 123: 1018–24. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C, et al. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol Psychiatry. 2008; 14: 705–18. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Celestino-Soper PB, Violante S, Crawford EL, Luo R, Lionel AC, Delaby E, et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci USA. 2012; 109: 7974–81. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Bayona-Bafaluy MP, Muller S, Moraes CT. Fast adaptive coevolution of nuclear and mitochondrial subunits of ATP synthetase in orangutan. Mol Biol Evol. 2005; 22: 716–24. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Nishigaki Y, Fuku N, Tanaka M. Mitochondrial haplogroups associated with lifestyle-related diseases and longevity in the Japanese population. Geriatr Gerontol Int. 2010; 10(Suppl 1): S221–35. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One. 2008; 3: e3815. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, et al. Mitochondrial dysfunction in autism. JAMA. 2010; 304: 2389–96. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Vali S, Mythri RB, Jagatha B, Padiadpu J, Ramanujan KS, Andersen JK, et al. Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model. Neuroscience. 2007; 149: 917–30. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Samavati L, Lee I, Mathes I, Lottspeich F, Huttemann M. Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem. 2008; 283: 21134–44. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Vempati UD, Diaz F, Barrientos A, Narisawa S, Mian AM, Millan JL, et al. Role of cytochrome C in apoptosis: increased sensitivity to tumor necrosis factor alpha is associated with respiratory defects but not with lack of cytochrome C release. Mol Cell Biol. 2007; 27: 1771–83. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation. 2003; 107: 1418–23. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011; 68: 1095–102. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, et al. Autism and environmental genomics. Neurotoxicology. 2006; 27: 671–84. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. 2004; 24: 664–73. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Fowler BA, Woods JS. Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function. Exp Mol Pathol. 1977; 27: 403–12. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Shenker BJ, Guo TL, O I, Shapiro IM. Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol. 1999; 157: 23–35. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Goyer RA. Toxic and essential metal interactions. Annu Rev Nutr. 1997; 17: 37–50. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Mihajlovic A, O'Brien PJ. Hepatocyte lysis induced by environmental metal toxins may involve apoptotic death signals initiated by mitochondrial injury. Adv Exp Med Biol. 2001; 500: 249–52.
   Web of Science ®Google Scholar
• Hiura TS, Li N, Kaplan R, Horwitz M, Seagrave JC, Nel AE. The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles. J Immunol. 2000; 165: 2703–11.
   PubMed Web of Science ®Google Scholar
• Wong PW, Garcia EF, Pessah IN. Ortho-substituted PCB95 alters intracellular calcium signaling and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. J Neurochem. 2001; 76: 450–63. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem. 2007; 100: 1469–79.
   PubMed Web of Science ®Google Scholar
• Yamano T, Morita S. Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes II. Arch Environ Contam Toxicol. 1995; 28: 1–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Astiz M, de Alaniz MJ, Marra CA. Effect of pesticides on cell survival in liver and brain rat tissues. Ecotoxicol Environ Saf. 2009; 72: 2025–32. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007; 176: 149–69. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• MacFabe DF, Rodriguez-Capote K, Hoffman JE, Franklin AE, Mohammad-Asef Y, Taylor A, et al. A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am J Biochem & Biotech. 2008; 4: 146–66. 10.3402/mehd.v23i0.19260.
   Google Scholar
• MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res. 2011; 217: 47–54. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, et al. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology. 2008; 54: 901–11. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Shultz SR, MacFabe DF, Martin S, Jackson J, Taylor R, Boon F, et al. Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res. 2009; 200: 33–41. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Thomas RH, Foley KA, Mepham JR, Tichenoff LJ, Possmayer F, MacFabe DF. Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders. J Neurochem. 2010; 113: 515–29. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Ossenkopp KP, Foley KA, Gibson J, Fudge MA, Kavaliers M, Cain DP, et al. Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats. Behav Brain Res. 2012; 227: 134–41. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S, et al. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation. 2012; 9: 153. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Midtvedt AC, Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastroenterol Nutr. 1992; 15: 395–403. 10.3402/mehd.v23i0.19260.
   Web of Science ®Google Scholar
• Patterson PH. Maternal infection and autism. Brain Behav Immun. 2012; 26: 393. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010; 14: 705–18.
   Google Scholar
• Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun. 2010; 24: 9–16. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time?. Nutr Clin Pract. 2006; 21: 351–66. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012; 336: 1262–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207–14. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Barnevik-Olsson M, Gillberg C, Fernell E. Prevalence of autism in children of Somali origin living in Stockholm: brief report of an at-risk population. Dev Med Child Neurol. 2010; 52: 1167–8. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010; 40: 1423–30. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Atladottir HO, Thorsen P, Schendel DE, Ostergaard L, Lemcke S, Parner ET. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch Pediatr Adolesc Med. 2010; 164: 470–7. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Finegold SM. Desulfovibrio species are potentially important in regressive autism. Med Hypotheses. 2011; 77: 270–4. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002; 35: S6–16. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010; 16: 444–53. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci. 2012; 57: 2096–102. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, et al. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 2002; 9: 179–88. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010; 1801: 1175–83. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne?. Exp Dermatol. 2005; 14: 143–52. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Borgstrom MK, Edwardsson S, Svensater G, Twetman S. Acid formation in sucrose-exposed dental plaque in relation to caries incidence in schoolchildren. Clin Oral Investig. 2000; 4: 9–12. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Niederman R, Zhang J, Kashket S. Short-chain carboxylic-acid-stimulated, PMN-mediated gingival inflammation. Crit Rev Oral Biol Med. 1997; 8: 269–90. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Zarate G, Gonzalez S, Chaia AP. Assessing survival of dairy propionibacteria in gastrointestinal conditions and adherence to intestinal epithelia. Methods Mol Biol. 2004; 268: 423–32.
   Google Scholar
• Brennan PA, Kendrick KM. Mammalian social odours: attraction and individual recognition. Philos Trans R Soc Lond B Biol Sci. 2006; 361: 2061–78. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Yonezawa T, Haga S, Kobayashi Y, Katoh K, Obara Y. Short-chain fatty acid signaling pathways in bovine mammary epithelial cells. Regul Pept. 2009; 153: 30–6. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Brock M, Buckel W. On the mechanism of action of the antifungal agent propionate. Eur J Biochem. 2004; 271: 3227–41. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Karuri AR, Dobrowsky E, Tannock IF. Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. Br J Cancer. 1993; 68: 1080–7. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Tamai I, Takanaga H, Maeda H, Sai Y, Ogihara T, Higashida H, et al. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem Biophys Res Commun. 1995; 214: 482–9. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Bergersen L, Rafiki A, Ottersen OP. Immunogold cytochemistry identifies specialized membrane domains for monocarboxylate transport in the central nervous system. Neurochem Res. 2002; 27: 89–96. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Conn AR, Fell DI, Steele RD. Characterization of alpha-keto acid transport across blood-brain barrier in rats. Am J Physiol. 1983; 245: E253–60.
   PubMed Web of Science ®Google Scholar
• Peinado A, Yuste R, Katz LC. Extensive dye coupling between rat neocortical neurons during the period of circuit formation. Neuron. 1993; 10: 103–14. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Maurer MH, Canis M, Kuschinsky W, Duelli R. Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci Lett. 2004; 355: 105–8. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Rafiki A, Boulland JL, Halestrap AP, Ottersen OP, Bergersen L. Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain. Neuroscience. 2003; 122: 677–88. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Nakao S, Moriya Y, Furuyama S, Niederman R, Sugiya H. Propionic acid stimulates superoxide generation in human neutrophils. Cell Biol Int. 1998; 22: 331–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• DeCastro M, Nankova BB, Shah P, Patel P, Mally PV, Mishra R, et al. Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Res Mol Brain Res. 2005; 142: 28–38. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Wajner M, Latini A, Wyse AT, Dutra-Filho CS. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis. 2004; 27: 427–48. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Hara H, Haga S, Aoyama Y, Kiriyama S. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999; 129: 942–8.
   PubMed Web of Science ®Google Scholar
• Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003; 278: 25481–9. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rorig B, Klausa G, Sutor B. Intracellular acidification reduced gap junction coupling between immature rat neocortical pyramidal neurones. J Physiol. 1996; 490(pt-1): 31–49.
   Web of Science ®Google Scholar
• Parab S, Nankova BB, La Gamma EF. Differential regulation of the tyrosine hydroxylase and enkephalin neuropeptide transmitter genes in rat PC12 cells by short chain fatty acids: concentration-dependent effects on transcription and RNA stability. Brain Res. 2007; 1132: 42–50. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Schreiber J, Chapman KA, Summar ML, Ah MN, Sutton VR, MacLeod E, et al. Neurologic considerations in propionic acidemia. Mol Genet Metab. 2012; 105: 10–5. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Nyhan WL, Bay C, Beyer EW, Mazi M. Neurologic nonmetabolic presentation of propionic acidemia. Arch Neurol. 1999; 56: 1143–7. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Al-Owain M, Kaya N, Al-Shamrani H, Al-Bakheet A, Qari A, Al-Muaigl S, et al. Autism spectrum disorder in a child with propionic acidemia. J Inherit Metab Dis. 2012. (in press).
   Google Scholar
• Perez B, Desviat LR, Rodriguez-Pombo P, Clavero S, Navarrete R, Perez-Cerda C, et al. Propionic acidemia: identification of twenty-four novel mutations in Europe and North America. Mol Genet Metab. 2003; 78: 59–67. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Yorifuji T, Kawai M, Muroi J, Mamada M, Kurokawa K, Shigematsu Y, et al. Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinical implications. Hum Genet. 2002; 111: 161–5. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Desviat LR, Perez B, Perez-Cerda C, Rodriguez-Pombo P, Clavero S, Ugarte M. Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol Genet Metab. 2004; 83: 28–37. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Haska L, Andersson R, Nyman M. The effect of dietary fiber from wheat processing streams on the formation of carboxylic acids and microbiota in the hindgut of rats. J Agric Food Chem. 2011; 59: 3406–13. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Stackebrandt E, Rainey FA. Phylogenetic relationships. The clostridia, molecular biology and pathogenesis. Rood JI, McClane BA, Songer JG, Titball RW. Academic Press: New York NY, 1997; 3–19.
   Google Scholar
• Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004; 70: 6459–65. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Finegold SM. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe. 2011; 17: 367–8. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Barton LL, Fauque GD. Biochemistry, physiology and biotechnology of sulfate-reducing bacteria. Adv Appl Microbiol. 2009; 68: 41–98.
   PubMed Web of Science ®Google Scholar
• Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta. 2010; 1797: 1500–11. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem. 2010; 113: 14–26. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• White JF. Intestinal pathophysiology in autism. Exp Biol Med. 2003; 228: 639–49.
   PubMed Web of Science ®Google Scholar
• Williams BL, Hornig M, Buie T, Bauman ML, Cho PM, Wick I, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011; 6: e24585. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135: 559–63. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005; 94: 386–93. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Nafday SM, Chen W, Peng L, Babyatsky MW, Holzman IR, Lin J. Short-chain fatty acids induce colonic mucosal injury in rats with various postnatal ages. Pediatr Res. 2005; 57: 201–4. 10.3402/mehd.v23i0.19260.
   Web of Science ®Google Scholar
• Mellon AF, Deshpande SA, Mathers JC, Bartlett K. Effect of oral antibiotics on intestinal production of propionic acid. Arch Dis Child. 2000; 82: 169–72. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006; 13: 171–81. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, et al. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J. 2009; 23: 2374–83. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Moy SS, Nadler JJ, Magnuson TR, Crawley JN. Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am J Med Genet C Semin Med Genet. 2006; 142: 40–51.
   Google Scholar
• Crawley JN. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 2007; 17: 448–59. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Hornig M, Chian D, Lipkin WI. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry. 2004; 9: 833–45. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, et al. Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther. 2007; 322: 16–22. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Lancaster K, Dietz DM, Moran TH, Pletnikov MV. Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav Brain Res. 2006; 176: 141–8. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007; 27: 10695–702. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Zwaigenbaum L, Bryson S, Rogers T, Roberts W, Brian J, Szatmari P. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci. 2005; 23: 143–52. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006; 26: 6897–906. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Crawley JN. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev. 2004; 10: 248–58. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Rinehart NJ, Tonge BJ, Iansek R, McGinley J, Brereton AV, Enticott PG, et al. Gait function in newly diagnosed children with autism: cerebellar and basal ganglia related motor disorder. Dev Med Child Neurol. 2006; 48: 819–24. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Feliz B, Witt DR, Harris BT. Propionic acidemia: a neuropathology case report and review of prior cases. Arch Pathol Lab Med. 2003; 127: e325–8.
   Google Scholar
• Besag FM. Behavioral aspects of pediatric epilepsy syndromes. Epilepsy Behav. 2004; 5(Suppl 1): S3–13. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Brusque AM, Mello CF, Buchanan DN, Terracciano ST, Rocha MP, Vargas CR, et al. Effect of chemically induced propionic acidemia on neurobehavioral development of rats. Pharmacol Biochem Behav. 1999; 64: 529–34. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Cannizzaro C, Monastero R, Vacca M, Martire M. [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions. Neurochem Int. 2003; 43: 9–17. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Mitsui R, Ono S, Karaki S, Kuwahara A. Neural and non-neural mediation of propionate-induced contractile responses in the rat distal colon. Neurogastroenterol Motil. 2005; 17: 585–94. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Moore H, Grace AA. A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology. 2002; 27: 980–92. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Sziray N, Leveleki C, Levay G, Marko B, Harsing LG Jr, Mikics E, et al. Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: the role of serotonin/noradrenaline balance and NMDA receptors. Brain Res Bull. 2007; 71: 376–85. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Neuhaus E, Beauchaine TP, Bernier R. Neurobiological correlates of social functioning in autism. Clin Psychol Rev. 2010; 30: 733–48. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• El-Ansary AK, Ben BA, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012; 9: 74. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Bingmann D, Wiemann M. Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones. Eur Neuropsychopharmacol. 2000; 10: 97–103. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Severson CA, Wang W, Pieribone VA, Dohle CI, Richerson GB. Midbrain serotonergic neurons are central pH chemoreceptors. Nat Neurosci. 2003; 6: 1139–40. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Shah P, Nankova BB, Parab S, La Gamma EF. Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein. Brain Res. 2006; 1107: 13–23. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML. Reduced cardiac parasympathetic activity in children with autism. Brain Dev. 2005; 27: 509–16. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rigo FK, Pasquetti L, Malfatti CR, Fighera MR, Coelho RC, Petri CZ, et al. Propionic acid induces convulsions and protein carbonylation in rats. Neurosci Lett. 2006; 408: 151–4. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Gogolla N, Leblanc JJ, Quast KB, Sudhof T, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord. 2009; 1: 172–81. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• de Almeida LM, Funchal C, Pelaez PL, Pessutto FD, Loureiro SO, Vivian L, et al. Effect of propionic and methylmalonic acids on the in vitro phosphorylation of intermediate filaments from cerebral cortex of rats during development. Metab Brain Dis. 2003; 18: 207–19. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Clavero S, Perez B, Rincon A, Ugarte M, Desviat LR. Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes. Hum Genet. 2004; 115: 239–47. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Hanstock TL, Clayton EH, Li KM, Mallet PE. Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of rats. Physiol Behav. 2004; 82: 357–68. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Puwanant M, Mo-Suwan L, Patrapinyokul S. Recurrent D-lactic acidosis in a child with short bowel syndrome. Asia Pac J Clin Nutr. 2005; 14: 195–8.
   PubMed Web of Science ®Google Scholar
• Brass EP, Beyerinck RA. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids. J Biochem. 1988; 250: 819–25.
   Google Scholar
• Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. Relative carnitine deficiency in autism. J Autism Dev Disord. 2004; 34: 615–23. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, et al. The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett. 2011; 201: 137–42. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Coulter DL. Carnitine, valproate, and toxicity. J Child Neurol. 1991; 6: 7–14. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Schulpis KH, Karikas GA, Tjamouranis J, Regoutas S, Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia. 2001; 42: 1359–62. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Koutouzis TK, Sanberg PR. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev. 1997; 21: 289–93. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins. Life Sci. 2004; 75: 2539–49. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem Res. 2012; 37: 1681–9. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Monks TJ, Ghersi-Egea JF, Philbert M, Cooper AJ, Lock EA. Symposium overview: the role of glutathione in neuroprotection and neurotoxicity. Toxicol Sci. 1999; 51: 161–77. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004; 80: 1611–7.
   PubMed Web of Science ®Google Scholar
• El-Ansary A, Al-Daihan S, Al-Dbass A, Al-Ayadhi L. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin Biochem. 2009; 43: 63–70. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009; 42: 1032–40. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Torres AR. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?. BMC Pediatr. 2003; 3: 9. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Neustadt J, Pieczenik SR. Medication-induced mitochondrial damage and disease. Mol Nutr Food Res. 2008; 52: 780–8. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism. 2008; 12: 293–307. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Noble M, Proschel C, Mayer-Proschel M. Oxidative-reductionist approaches to stem and progenitor cell function. Cell Stem Cell. 2011; 8: 1–2. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rorig B, Sutor B. Serotonin regulates gap junction coupling in the developing rat somatosensory cortex. Eur J Neurosci. 1996; 8: 1685–95. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Anders JJ. Lactic acid inhibition of gap junctional intercellular communication in in vitro astrocytes as measured by fluorescence recovery after laser photobleaching. GLIA. 1988; 1: 371–9. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Frantseva MV, Kokarovtseva L, Naus CG, Carlen PL, MacFabe D, Perez Velazquez JL. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci. 2002; 22: 644–53.
   PubMed Web of Science ®Google Scholar
• Perez-Velazquez JL, Frantseva MV, Naus CC. Gap junctions and neuronal injury: protectants or executioners?. Neuroscientist. 2003; 9: 5–9. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Juszczak GR, Swiergiel AH. Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33: 181–98. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Wiencken-Barger AE, Djukic B, Casper KB, McCarthy KD. A role for Connexin43 during neurodevelopment. GLIA. 2007; 55: 675–86. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Nagasawa K, Chiba H, Fujita H, Kojima T, Saito T, Endo T, et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol. 2006; 208: 123–32. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol. 2007; 17: 434–47. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Madhusudan A, Vogel P, Knuesel I. Impact of prenatal immune system disturbances on brain development. J Neuroimmune Pharmacol. in press.
   Web of Science ®Google Scholar
• Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal. 2005; 7: 1223–33. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005; 28: 436–45. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu L, Zhu X, Cui W, Sun Y, Nishijo H, et al. Demethylation of specific Wnt/beta-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure. Anat Rec (Hoboken). 2010; 293: 1947–53. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Nankova BB, La Gamma EF, Taylor AR, Tichenoff L, MacFabe DF. Intraventricular enteric short chain fatty acid infusions in rats induce behavioural, neuropathological, lipid and epigenetic changes consistent with Autism. abstr. International Meeting for Autism Research, May 17–19, 2012, Toronto.
   Google Scholar
• Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?. Prostaglandins Leukot Essent Fatty Acids. 2000; 63: 21–5. 10.3402/mehd.v23i0.19260.
   PubMedGoogle Scholar
• Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001; 65: 1–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids. 2004; 70: 383–90. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007; 61: 551–3. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Wiest MM, German JB, Harvey DJ, Watkins SM, Hertz-Picciotto I. Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot Essent Fatty Acids. 2009; 80: 221–7. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Tamiji J, Crawford DA. The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals. 2010; 18: 98–112. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids. 2004; 71: 201–4. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Meguid NA, Atta HM, Gouda AS, Khalil RO. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin Biochem. 2008; 41: 1044–8. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Aneja A, Tierney E. Autism: the role of cholesterol in treatment. Int Rev Psychiatry. 2008; 20: 165–70. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Champeil-Potokar G, Chaumontet C, Guesnet P, Lavialle M, Denis I. Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur J Neurosci. 2006; 24: 3084–90. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Zhao S, Jia L, Gao P, Li Q, Lu X, Li J, et al. Study on the effect of eicosapentaenoic acid on phospholipids composition in membrane microdomains of tight junctions of epithelial cells by liquid chromatography/electrospray mass spectrometry. J Pharm Biomed Anal. 2008; 47: 343–50. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Prog Lipid Res. 2010; 49: 61–75. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Clarke JT, Clark-Taylor BE. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses. 2004; 62: 970–5. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Frye RE. Biomarkers of abnormal energy metabolism in children with autism spectrum disorder. N Am J Med Sci. in press.
   Google Scholar
• Pastural E, Ritchie S, Lu Y, Jin W, Kavianpour A, Khine Su-Myat K, et al. Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids. 2009; 81: 253–64. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Bu B, Ashwood P, Harvey D, King IB, Water JV, Jin LW. Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids. 2006; 74: 215–21. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Brass EP, Fennessey PV, Miller LV. Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. Biochem J. 1986; 236: 131–6.
   PubMed Web of Science ®Google Scholar
• Roe RC, Millington DS, Maltby DA, Bohan TP, Hoppel CL. L-carnitine enhances excretion of propoinyl coenzyme A as propionylcarnitine in propoinic acidemia. J Clin Invest. 1984; 73: 1785–8. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Tonin AM, Grings M, Knebel LA, Zanatta A, Moura AP, Ribeiro CA, et al. Disruption of redox homeostasis in cerebral cortex of developing rats by acylcarnitines accumulating in medium-chain acyl-CoA dehydrogenase deficiency. Int J Dev Neurosci. 2012; 30: 383–90. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Schwab MA, Sauer SW, Okun JG, Nijtmans LG, Rodenburg RJ, van den Heuvel LP, et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J. 2006; 398: 107–12. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Brass EP. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability. J Nutr. 1992; 122: 234–40.
   Web of Science ®Google Scholar
• Wolever TM, Fernandes J, Rao AV. Serum acetate: propionate ratio is related to serum cholesterol in men but not women. J Nutr. 1996; 126: 2790–7.
   PubMed Web of Science ®Google Scholar
• Wolever TM, Spadafora PJ, Cunnane SC, Pencharz PB. Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. Am J Clin Nutr. 1995; 61: 1241–7.
   PubMed Web of Science ®Google Scholar
• James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006; 141: 947–56.
   Google Scholar
• Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E, et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010; 119: 755–70. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Scafidi S, Fiskum G, Lindauer SL, Bamford P, Shi D, Hopkins I, et al. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem. 2010; 114: 820–31. 10.3402/mehd.v23i0.19260.
   Google Scholar
• James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009; 89: 425–30. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Miecz D, Januszewicz E, Czeredys M, Hinton BT, Berezowski V, Cecchelli R, et al. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. J Neurochem. 2008; 104: 113–23.
   PubMed Web of Science ®Google Scholar
• Yamamoto-Furusho JK, Mendivil-Rangel EJ, Villeda-Ramirez MA, Fonseca-Camarillo G, Barreto-Zuniga R. Gene expression of carnitine organic cation transporters 1 and 2 (OCTN) is downregulated in patients with ulcerative colitis. Inflamm Bowel Dis. 2011; 17: 2205–6. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Yao D, Kuwajima M, Chen Y, Shiota M, Okumura Y, Yamada H, et al. Impaired long-chain fatty acid metabolism in mitochondria causes brain vascular invasion by a non-neurotropic epidemic influenza A virus in the newborn/suckling period: implications for influenza-associated encephalopathy. Mol Cell Biochem. 2007; 299: 85–92. 10.3402/mehd.v23i0.19260.
   Google Scholar
• Fallon J. Could one of the most widely prescribed antibiotics amoxicillin/clavulanate “augmentin” be a risk factor for autism?. Med Hypotheses. 2005; 64: 312–5. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000; 15: 429–35. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Mann JR, McDermott S, Bao H, Hardin J, Gregg A. Pre-eclampsia, birth weight, and autism spectrum disorders. J Autism Dev Disord. 2010; 40: 548–54. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Thiele IG, Niezen-Koning KE, van Gennip AH, Aarnoudse JG. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol. 2004; 103: 876–80. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Scafidi S, Racz J, Hazelton J, McKenna MC, Fiskum G. Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Dev Neurosci. 2010; 32: 480–7.
   Web of Science ®Google Scholar
• Patel SP, Sullivan PG, Lyttle TS, Rabchevsky AG. Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem. 2010; 114: 291–301.
   Web of Science ®Google Scholar
• Fortin G, Yurchenko K, Collette C, Rubio M, Villani AC, Bitton A, et al. L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation. Clin Exp Immunol. 2009; 156: 161–71. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009; 9: 21. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Willner P. The validity of animal models of depression. Psychopharmacology (Berl). 1984; 83: 1–16. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Willner P. Animal models as simulations of depression. Trends Pharmacol Sci. 1991; 12: 131–6. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Bresolin N, Freddo L, Vergani L, Angelini C. Carnitine, carnitine acyltransferases, and rat brain function. Exp Neurol. 1982; 78: 285–92. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Kavaliers M, Choleris E, Agmo A, Pfaff DW. Olfactory-mediated parasite recognition and avoidance: linking genes to behavior. Horm Behav. 2004; 46: 272–83. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Kaushik M, Lamberton PH, Webster JP. The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Horm Behav. in press.
   Web of Science ®Google Scholar
• Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA. 2011; 108: 3047–52. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Suren P, Bakken IJ, Aase H, Chin R, Gunnes N, Lie KK, et al. Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in norwegian children. Pediatrics. 2012; 130: e152–8. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Sokol MS. Infection-triggered anorexia nervosa in children: clinical description of four cases. J Child Adolesc Psychopharmacol. 2000; 10: 133–45. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Kerbeshian J, Burd L. Is anorexia nervosa a neuropsychiatric developmental disorder? An illustrative case report. World J Biol Psychiatry. 2009; 10: 648–57. 10.3402/mehd.v23i0.19260.
   PubMed Web of Science ®Google Scholar
• Diamond J. Guns, germs, and steel. New York: W.W. Norton & Company. 1997.
   Google Scholar
• Foley KA, Kavaliers M, Ossenkopp K-P, MacFabe DF. Prenatal exposure to propionic acid and lipopolysaccharides produces developmental delay, anxiety-like behaviour, and hyper-sensitivity to accoustic startle in adolescent rats. abstr. International Meeting for Autism Research, May17–19, 2012, Toronto.
   Google Scholar